Tin tức & Cập nhật

Have you got your "Eye on AAO?" Download the 2017 e-bulletins here

The latest research, clinical data and innovations in ophthalmology were presented at the 2017 Annual Meeting of the American Academy of Ophthalmology (AAO) in New Orleans, USA, held on 11−14 November 2017. As in previous years, an international panel of renowned ophthalmologists were supported by Pfizer to attend the meeting and contribute articles to create the Eye on AAO 2017 e-Bulletins. Delivered immediately after each meeting day, and developed with full editorial independence, these e-bulletins feature conference highlights of the latest research, hot topics in ophthalmology and their relevance to the Asia Pacific region.

The e-Bulletins are now collected together and available for download from this page; they are sure to be of significant interest to those seeking the latest advances in ophthalmology.

Maternal rheumatoid arthritis carries risk of ASD in offspring

Infants born to mothers with rheumatoid arthritis (RA) during pregnancy are at risk of autism spectrum disorder (ASD), according to a study.

GSK’s Successful Launch of Sensodyne Repair and Protect Deep Repair

Tooth sensitivity is a clinically important problem that affects a considerable proportion of the adult population. It can exert significant burden on patients and may largely affect their quality of life which highlights the need for effective solutions against dentine hypersensitivity. However, the limitations that the COVID pandemic has brought about has greatly altered patients’ health-seeking behavior and ultimately, the dynamics of the relationship between dentists and their patients. As such, there is a need for novel solutions that patients can rely on to effectively address dentine hypersensitivity.

Higher aspirin dose may attenuate severe pre-eclampsia risk among high-risk women with obesity

Doubling the routine aspirin dose used for pre-eclampsia prevention appears to help lower the risk of developing pre-eclampsia with severe features among high-risk pregnant women with obesity, according to the results of the open-label ASPREO trial.

Family-oriented primary care underappreciated in Vietnam

Maternal transplacental transfer of nipocalimab negligible in foetuses, neonates

In the phase II UNITY study, foetuses and neonates whose mums were receiving nipocalimab for early-onset (≤24 weeks gestational age [GA]) severe haemolytic disease of the foetus and newborn (EOS-HDFN) had minimal exposure to the drug.